Coronavirus: Can vitamins really help with a COVID-19 infection?

There are a growing number of studies looking at the effect of micronutrients on people infected with SARSCoV-2. Vitamin D seems to be a promising candidate for reducing the severity of COVID-19. DW looks at the facts.

As we all know, people can disagree about almost anything. However, one thing that is undisputed is that a good supply of micronutrients, such as vitamins and minerals, is essential for a functioning immune system.

This is reason enough for many researchers around the world to investigate whether individual micronutrients used in a targeted manner can make a COVID-19 infection less severe and thus prevent serious consequences or even death from the disease.

Vitamin D is one of the most popular subjects of research. And some of the published studies sound quite promising, such as the work of the Spanish pneumologist Marta Castillo.

"This is one of the studies that is repeatedly cited as proving the effectiveness of vitamin D," says Martin Smollich, a pharmacologist and professor at the Institute of Nutritional Medicine at the University Medical Center Schleswig-Holstein in the northern German city of Lübeck.

Smollich himself conducts research on micronutrients and dietary supplements. At a time when the influence of vitamins and Co. is either greatly exaggerated for ideological and business reasons or dismissed with contemptuous derision, Smollich is trying to put together a more differentiated picture.

Seeming evidence

At first glance, the results of Castillo's study seem to give cause for optimism: Of the 50 COVID-19 patients who were given vitamin D, only one landed on the intensive care unit, while in the control group, where no vitamin D was administered, 50% needed intensive care.

"With such studies, it is important as the first step to look at how these two groups are put together," says Smollich. For the study to be able to truly answer the question about the effectiveness of vitamin D, the two groups would have to have as similar a composition as possible.

Problematic methodology

But that is exactly where the problem with this study lies. It lists some risk factors and provides information on how many patients were suffering from certain preexisting conditions (see Table 2), such as Type 2 diabetes.

"Only 6% of the test persons in the group that received vitamin D were diabetics, whereas 19% of the people who were given only a placebo had the condition," says Smollich.

The problems in the study with regard to high blood pressure are even more serious: Fiftyseven percent of the participants who were not given vitamin D suffered from the condition, while in the other group, too high blood pressure was found in only 24% of the test persons.

"This means that the group without vitamin D had the sickest people," summarizes the pharmacologist. And such heterogeneous groups distort the results.

"With COVID-19, we know that both diabetes and high blood pressure are risk factors that are likely to cause a severe progression of the disease," says Smollich. "So it's no wonder that patients in the group without vitamin D ended up in intensive care more often."

A study carried out with such imprecise methodology cannot answer the question of whether the test persons in the control group had to be treated more often in intensive care because they lacked vitamin D or because they had more serious preexisting conditions.

Numerous other studies and reviews have so far concluded that administering vitamin D does not have a significant influence on the severity of a COVID-19 infection.

But...!

Type 2 diabetes, obesity and high blood pressure have things in common: They are not only risk factors for severe COVID-19 infections, but are also all dietrelated diseases.

So it is mistaken to think that nutrition and nutrient status play no role in dealing with the coro

navirus pandemic. In fact, the opposite is true.

"Nutrients are important for various levels of the immune system," says Anika Wagner, professor of Nutrition and Immune System at the University of Giessen. A nutrient deficiency weakens the various defense mechanisms of the immune system and makes it much easier for harmful bacteria and viruses to cause damage.

Are dietary supplements necessary?

In addition to the question of how important micronutrients are for the prevention of disease, there is also constant debate about whether our immune system is adequately supplied by healthy food alone or whether it needs dietary supplements to be at its best.

The answer is: It depends. "In principle, I recommend that the need for nutrients be covered by the daily diet," says Wagner.

However, the increasing rate of obesity suggests that far too many people are failing to practically implement a healthy diet and are thus not receiving an adequate supply of nutrients.

"Often, obese people consume more food with a high energy density, but which contains only a few micronutrients," says Wagner. That includes sugary drinks, ready meals and sweets.

"At some point, the obese person may even develop diabetes and high blood pressure," she says. The lack of nutrients weakens the immune system, while being overweight and having diabetes and/or high blood pressure pave the way for a severe bout of COVID-19.

Here again, vitamin D comes into play: A vitamin D deficiency occurs "with above-average frequency in cases where there are illnesses and conditions that in themselves increase the COVID-19 risk: advanced age, obesity or Type 2 diabetes," Martin Smollich writes in his specialist blog Ernährungsmedizin, which deals with aspects of clinical nutrition.

This vicious circle is neither new nor unknown. "Many preexisting conditions that have a bearing on coronavirus disease could have been averted by effective prevention," the German Diabetes Society (DDG) said in a press release in May.

"In Germany, the connection between diet and disease is often completely ignored. And I find that very dramatic, because it is something that could have been modified," says Smollich. "Instead, the coronavirus pandemic hit a society in which dietrelated diseases are almost the norm."

Old and chronically ill people need more nutrients

Another risk group could benefit from prioritizing nutrients for health: the elderly. "We know that the immune system does not function as well in old age and that the possibilities for vitamin D synthesis also decrease," says Anika Wagner.

Here, she says, the use of supplements should be considered.

The Federal Institute for Risk Assessment (BfR) comes to the same conclusion. It recommends vitamin D supplements for older and chronically ill people, especially if they are dependent on care.

What is more important than taking individual micronutrients is making sure that people generally have an optimized intake of nutrients so that a range of diseases can be prevented, Smollich writes in his blog. "Appropriate nutritional and health policy measures would seem more urgently needed than ever in view of the coronavirus pandemic," he writes.

duce antibodies against this protein and thus the virus.

When will the vaccines be approved?

The approval process differs in the United States and European Union. Intermediate tests are designed to speed up the procedure.

BioNTech and Pfizer have announced that they will request emergency use authorization (EUA) for their vaccine from the US Food and Drug Administration (FDA) in the coming weeks. By this time, a minimum two-month observation period after the second vaccine shot will have passed. This is an FDA requirement. Moderna similarly plans to request a EUA from the FDA in coming weeks.

It is unclear when BioNTech will request the stricter European Medicines Agency (EMA) to approve its vaccine. In Germany, the Paul Ehrlich Institute tests and approves vaccines for public use.

It looks likely that a coronavirus vaccine will become available in Europe later this year, or in early 2021, thanks to the EU's fast-tracked approval process.

Challenges ahead

For months, the EU has been in talks with BioNTech and Pfizer. Initially, the bloc aimed to secure up to 300 million vaccine doses. A contract drawn up between the parties now places an order for 200 million doses, with the option of a further 100 million.

The Commission is reportedly also negotiating with Moderna to secure up to 160 million doses of its vaccine. So far, however, no contract has been finalized.

In addition, the EU has struck a deal to buy 300 million vaccine doses from AstraZeneca. It has also reached deals with SanofiGSK and Johnson & Johnson.

In early June, Germany, France, Italy and the Netherlands joined forces to create the socalled Inclusive Vaccine Alliance, which will aim to boost vaccine production in as many locations across the EU as possible as soon as possible.

This way, the EU plans not only to make affordable vaccines available to member states but also to poorer nations, for example in Africa.

Read more: COVID-19: Global alliance comes to Africa's rescue in vaccine rush

Yet big questions still remain over how the vaccines will be distributed and administered across the globe. Most will presumably need to be permanently stored at minus 80 degrees Celsius, which poses a major logistical challenge.

This article was translated from German. It has been updated on November 19, 2020 to include the publication of the study on the Oxford-vaccine.